换一批Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective study.
第一作者：
Xiang,Ren
第一单位：
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
作者：
医学主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);顺铂(Cisplatin);脱氧胞苷(Deoxycytidine);人类(Humans);试点项目(Pilot Projects);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1186/s12894-022-01083-8
PMID
35987640
发布时间
2022-12-07
- 浏览14
BMC urology
128页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
